Category: Sleep Treatments

Sleep Treatments

Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X

The granted patent protects the proprietary oral combination therapy through at least 2040, as the company prepares to launch its Phase 2 dose optimization study.

Sleep Treatments

Positive Interim Analysis Advances Avecho Phase III Insomnia Trial for CBD Capsule

Avecho Biotechnology will proceed to full enrollment in its phase III insomnia trial after an independent board found no serious adverse events in an interim analysis of its TPM-enhanced CBD capsule. The company is now preparing to engage with the FDA and international regulators to determine potential commercial pathways for the treatment.

Sleep Treatments

Surprising Duration of Self-Maintained Positional Therapy Benefits Offers New OSA Strategy

Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.

CPAP & PAP Devices

How to Afford CPAP + GLP-1 Polytherapy

What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?

Insomnia Devices

Nexalin Acquires Digital Health Platform Ahead of FDA Pivotal Trial for Insomnia Treatment

The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.

Therapy Devices

Nyxoah Initiates Search for US-Based CEO to Accelerate Genio Launch

The medical technology company is transitioning leadership to focus on its next phase of growth and commercial traction for its obstructive sleep apnea therapy in the US market.

Pharmaceuticals

Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial

Phase 3 TRIUMPH-1 trial data show retatrutide reduced the AHI by up to 36.1 events per hour alongside substantial weight loss.

Surgeries & Procedures

Which Costs Less: GLP-1s or Bariatric Surgery?

A retrospective study explores how surgical and pharmacologic weight-loss strategies stack up in cost, effectiveness, and health outcomes.

Behavioral Sleep Medicine

New DARC-NESS Model Explains Why Nightmares Persist in Children

A mastery-based cognitive-behavioral model centers on "nightmare efficacy" to help clinicians create personalized treatment plans for youth.